Hypospadias Prevalence and Trends in International Birth Defect Surveillance Systems, 1980-2010.

Hypospadias International Clearinghouse for Birth Defects Surveillance and Research Joinpoint regression Prevalence Trend

Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
10 2019
Historique:
received: 26 02 2019
accepted: 20 06 2019
pubmed: 14 7 2019
medline: 5 1 2021
entrez: 14 7 2019
Statut: ppublish

Résumé

Hypospadias is a common male birth defect that has shown widespread variation in reported prevalence estimates. Many countries have reported increasing trends over recent decades. To analyze the prevalence and trends of hypospadias for 27 international programs over a 31-yr period. The study population included live births, stillbirths, and elective terminations of pregnancy diagnosed with hypospadias during 1980-2010 from 27 surveillance programs around the world. We used joinpoint regression to analyze changes over time in international total prevalence of hypospadias across programs, prevalence for each specific program, and prevalence across different degrees of severity of hypospadias. The international total prevalence of hypospadias for all years was 20.9 (95% confidence interval: 19.2-22.6) per 10000 births. The prevalence for each program ranged from 2.1 to 39.1 per 10000 births. The international total prevalence increased 1.6 times during the study period, by 0.25 cases per 10000 births per year (p<0.05). When analyzed separately, there were increasing trends for first-, second-, and third-degree hypospadias during the early 1990s to mid-2000s. The majority of programs (61.9%) had a significantly increasing trend during many of the years evaluated. Limitations include known differences in data collection methods across programs. Although there have been changes in clinical practice and registry ascertainment over time in some countries, the consistency in the observed increasing trends across many programs and by degrees of severity suggests that the total prevalence of hypospadias may be increasing in many countries. This observation is contrary to some previous reports that suggested that the total prevalence of hypospadias was no longer increasing in recent decades. We report on the prevalence and trends of hypospadias among 27 birth defect surveillance systems, which indicate that the prevalence of hypospadias continues to increase internationally.

Sections du résumé

BACKGROUND
Hypospadias is a common male birth defect that has shown widespread variation in reported prevalence estimates. Many countries have reported increasing trends over recent decades.
OBJECTIVE
To analyze the prevalence and trends of hypospadias for 27 international programs over a 31-yr period.
DESIGN, SETTING, AND PARTICIPANTS
The study population included live births, stillbirths, and elective terminations of pregnancy diagnosed with hypospadias during 1980-2010 from 27 surveillance programs around the world.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
We used joinpoint regression to analyze changes over time in international total prevalence of hypospadias across programs, prevalence for each specific program, and prevalence across different degrees of severity of hypospadias.
RESULTS AND LIMITATIONS
The international total prevalence of hypospadias for all years was 20.9 (95% confidence interval: 19.2-22.6) per 10000 births. The prevalence for each program ranged from 2.1 to 39.1 per 10000 births. The international total prevalence increased 1.6 times during the study period, by 0.25 cases per 10000 births per year (p<0.05). When analyzed separately, there were increasing trends for first-, second-, and third-degree hypospadias during the early 1990s to mid-2000s. The majority of programs (61.9%) had a significantly increasing trend during many of the years evaluated. Limitations include known differences in data collection methods across programs.
CONCLUSIONS
Although there have been changes in clinical practice and registry ascertainment over time in some countries, the consistency in the observed increasing trends across many programs and by degrees of severity suggests that the total prevalence of hypospadias may be increasing in many countries. This observation is contrary to some previous reports that suggested that the total prevalence of hypospadias was no longer increasing in recent decades.
PATIENT SUMMARY
We report on the prevalence and trends of hypospadias among 27 birth defect surveillance systems, which indicate that the prevalence of hypospadias continues to increase internationally.

Identifiants

pubmed: 31300237
pii: S0302-2838(19)30517-2
doi: 10.1016/j.eururo.2019.06.027
pmc: PMC7265200
mid: NIHMS1578593
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

482-490

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 European Association of Urology. All rights reserved.

Références

Arch Dis Child Fetal Neonatal Ed. 2004 Mar;89(2):F149-51
pubmed: 14977900
Arch Dis Child. 2007 Jul;92(7):576-9
pubmed: 17142312
J Pediatr Urol. 2016 Jun;12(3):152.e1-7
pubmed: 26810252
Urology. 2001 Jan;57(1):151-3
pubmed: 11164162
Int Braz J Urol. 2017 Mar-Apr;43(2):325-334
pubmed: 27802003
Ital J Pediatr. 2009 Jun 27;35:18
pubmed: 19558700
Environ Health Perspect. 2000 May;108(5):463-5
pubmed: 10811575
J Epidemiol. 2004 May;14(3):73-7
pubmed: 15242062
Environ Health Perspect. 2004 Mar;112(3):398-402
pubmed: 14998760
Pediatrics. 1997 Nov;100(5):831-4
pubmed: 9346983
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S31-43
pubmed: 21381187
Arch Argent Pediatr. 2010 Oct;108(5):409-17
pubmed: 21132229
Environ Health Perspect. 1999 Apr;107(4):297-302
pubmed: 10090709
World J Urol. 2015 Dec;33(12):2159-67
pubmed: 25712311
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Acta Paediatr Hung. 1986;27(4):329-37
pubmed: 3593583
Birth Defects Res. 2019 Apr 1;111(6):333-340
pubmed: 30756506
Birth Defects Res A Clin Mol Teratol. 2004 Feb;70(2):75-81
pubmed: 14991914
Birth Defects Res A Clin Mol Teratol. 2015 Nov;103(11):972-93
pubmed: 26611917
Pediatrics. 2005 Apr;115(4):e495-9
pubmed: 15741350
Acta Paediatr Scand Suppl. 1986;324:1-52
pubmed: 3471045
Birth Defects Res A Clin Mol Teratol. 2012 Nov;94(11):893-9
pubmed: 22945024
Birth Defects Res. 2019 Apr 1;111(6):324-332
pubmed: 30746866
Arch Dis Child. 2007 Jul;92(7):580-4
pubmed: 17405856

Auteurs

Xiao Yu (X)

School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.

Natasha Nassar (N)

Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Pierpaolo Mastroiacovo (P)

Centre of the International Clearinghouse for Birth Defects Surveillance and Research, Rome, Italy.

Mark Canfield (M)

Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, USA.

Boris Groisman (B)

National Network of Congenital Anomalies of Argentina (RENAC), National Center of Medical Genetics, National Administration of Laboratories and Health Institutes (ANLIS), National Ministry of Health, Buenos Aires, Argentina.

Eva Bermejo-Sánchez (E)

ECEMC, Centro de Investigación sobre Anomalías Congénitas (CIAC), Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III, Madrid, Spain.

Annukka Ritvanen (A)

Finnish Register of Congenital Malformations, National Institute for Health and Welfare, Helsinki, Finland.

Sonja Kiuru-Kuhlefelt (S)

Finnish Register of Congenital Malformations, National Institute for Health and Welfare, Helsinki, Finland.

Adriana Benavides (A)

Centro de Registro de Enfermedades Congénitas (CREC), Unidad de Enfermedades Congénitas, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), Cartago, Costa Rica.

Antonin Sipek (A)

Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic.

Anna Pierini (A)

Institute of Clinical Physiology, National Research Council (IFC-CNR), Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Fabrizio Bianchi (F)

Institute of Clinical Physiology, National Research Council (IFC-CNR), Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Karin Källén (K)

National Board of Health and Social Welfare, Stockholm, Sweden.

Miriam Gatt (M)

Malta Congenital Anomalies Registry, Directorate for Health Information and Research, G'mangia Hill, G'mangia, Malta.

Margery Morgan (M)

Congenital Anomaly Register & Information Service for Wales (CARIS), Public Health Wales, Swansea, Wales, UK.

David Tucker (D)

Congenital Anomaly Register & Information Service for Wales (CARIS), Public Health Wales, Swansea, Wales, UK.

M Aaurora Canessa (MA)

Regional Register Congenital Malformation Maule Health Service (RRMC-SSM), Maule, Chile.

Rosa Gajardo (R)

Regional Register Congenital Malformation Maule Health Service (RRMC-SSM), Maule, Chile.

Osvaldo M Mutchinick (OM)

Department of Genetics, Registry and Epidemiological Surveillance of Congenital Malformations (RYVEMCE), Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.

Elena Szabova (E)

Slovak Medical University, FPH, Limbova, Bratislava, Slovak Republic.

Melinda Csáky-Szunyogh (M)

Hungarian Congenital Abnormalities Registry and Rare Disease Centre, National Public Health Center, Budapest, Hungary.

Giovanna Tagliabue (G)

Lombardy Cancer Registry Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Janet D Cragan (JD)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Wendy N Nembhard (WN)

Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences and Arkansas Reproductive Health Monitoring System, Little Rock, AR, USA.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Dorit Goetz (D)

Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Carol Bower (C)

Telethon Kids Institute, Subiaco, Western Australia, Australia.

Gareth Baynam (G)

Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Western Australian Register of Developmental Anomalies, Western Australian Department of Health, Perth, Australia.

R Brian Lowry (RB)

Alberta Congenital Anomalies Surveillance System, Department Clinical Genetics, Alberta Children's Hospital, Calgary, AB, Canada.

Juan A Leon (JA)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Wei Luo (W)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Jocelyn Rouleau (J)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Ignacio Zarante (I)

Instituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, Colombia.

Nicolas Fernandez (N)

Division of Pediatric Urology, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.

Emmanuelle Amar (E)

Registre Des Malformations En Rhone-Alpes, REMERA (ex Central-East France Register of Congenital Malformations, IEG), Lyon, France.

Saeed Dastgiri (S)

Tabriz Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran.

Paolo Contiero (P)

Lombardy Birth Defect Registry, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Laura E Martínez-de-Villarreal (LE)

Genetics Department, Medical School, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.

Barry Borman (B)

New Zealand Birth Defects Registry, Massey University, Wellington, New Zealand.

J E H Bergman (JEH)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Hermien E K de Walle (HEK)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Charlotte A Hobbs (CA)

Rady Children's Institute for Genomic Medicine, San Diego, CA, USA.

Amy E Nance (AE)

Utah Birth Defect Network, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, UT, USA.

A J Agopian (AJ)

School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: a.j.agopian@uth.tmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH